Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/73477
Title: Development of novel gene delivery system for cancer therapy
Authors: Yang, Chengbin
Keywords: DRNTU::Engineering::Electrical and electronic engineering
Issue Date: 2018
Source: Yang, C. (2018). Development of novel gene delivery system for cancer therapy. Doctoral thesis, Nanyang Technological University, Singapore.
Abstract: In this thesis, novel biodegradable charged polyester-based vectors (BCPVs) were designed and synthesized as siRNA carrier for cancer treatment. Under optimized conditions, the BCPV can effectively protect siRNA from degradation by RNase in the serum, and would subsequently promote intracellular siRNA uptake via endocytosis. The formulation and usage of BCPV-based siRNA carriers cause significant inhibition of targeted abnormal proto‐oncogenes expression in adherent growth cells (pancreatic cancer cell line) and non-adherent growth cells (leukemia cell line), resulting in obvious inhibition of cancer cell bioactivity. In addition, BCPV was able to simultaneously co-deliver K-ras and Notch1 siRNA into pancreatic cancer cells to overcome chemotherapeutic drug resistance (Gemcitabine) by reversing the epithelial-mesenchymal transition (EMT). Lastly, BCPV, as modifying polymer, was used to coat the surface of graphene quantum dots (GQDs) for fabrication of multifunctional siRNA and drug co-delivery systems, which realized real-time monitoring of the delivery efficacy and distribution of the drugs and siRNA.
URI: http://hdl.handle.net/10356/73477
DOI: 10.32657/10356/73477
Schools: School of Electrical and Electronic Engineering 
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:EEE Theses

Files in This Item:
File Description SizeFormat 
EEE_Thesis_YANG CHENGBIN.pdfMain article8.68 MBAdobe PDFThumbnail
View/Open

Page view(s) 50

633
Updated on May 7, 2025

Download(s) 20

230
Updated on May 7, 2025

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.